Corrigendum to “Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study” [Eur. J. Cancer, vol. 205 (2024) 114119]
Titel:
Corrigendum to “Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study” [Eur. J. Cancer, vol. 205 (2024) 114119]
Auteur:
Noujaim, Jonathan Gupta, Abha A. Holloway, Caroline L. Saleh, Ramy Srikanthan, Amirrtha Lemieux, Christopher Soroka, Hagit Peretz Tibout, Pauline Turcotte, Robert Feng, Xiaolan Abdul Razak, Albiruni R. Costa, Philippos